SGMO - Sangamo Therapeutics GAAP EPS of -$0.08 misses by $0.04, revenue of $18.3M misses by $13.38M
2025-08-07 16:04:52 ET
More on Sangamo Therapeutics
- Sangamo Therapeutics, Inc. (SGMO) Q1 2025 Earnings Call Transcript
- Sangamo Therapeutics, Inc. 2025 Q1 - Results - Earnings Call Presentation
- Sangamo Therapeutics Q2 2025 Earnings Preview
- Sangamo rises after trial data for Fabry disease therapy
- Seeking Alpha’s Quant Rating on Sangamo Therapeutics